K. Chiang-ngernthanyakun, “Sodium Glucose Cotransporter 2 Inhibitor and Glucagon-like Peptide 1 Receptor Agonist: New Glucose-lowering Medications and Cardiovascular Outcome”, CM Dent J, vol. 42, no. 1, pp. 199–215, Apr. 2021.